front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |review |
Otras:
•Janerich
et al. “Lung cancer and exposure to tobacco smoke in the household”.
N Engl J Med 323:632-636, 1990.
•Cardenas
et al. “Nonsmoking women married to smokers die of lung cancer more
often than women married to nonsmokers.” Environmental tobacco smoke
and lung cancer mortality in the American Cancer Society’s Cancer
prevention Study II. Cancer causes and Control, 1997:8;57-64.
•Mulshine
et al. “Application of monoclonal antibodies for use in the early
detection and management of lung cancer”. Second International
Workshop on Small Cell Lung Cancer Antigens. London 1990.
•Gealy
et al. “Comparison of Mutations in the p53 and K-ras genes in Lung
Carcinomas from smoking and nonsmoking women.”
Cancer Epidemiology, Biomarkers and Prevention 8, 297-302,
April 1999.
•Tammemagi
et al. “Meta-analyses of p53 Tumor Suppressor gene alterations and
clinicopathological features in resected lung cancers.” Cancer
Epidemiology, Biomarkers and Prevention 8, 625-634, July 1999.
•“Lung
Cancer: Prevention, Diagnosis and Treatment”. Review from “2nd Nordic
Symposium on Lung Cancer”. Editor FR. Hirsch. ISBN 87-984474-1-6.
•Gadgeel
et al. “Lung cancer in patients < 50 years of age. The Experience of
an Academic Multidisciplinary Program.” Chest 115(5): 1232 –1236,
1999.
•Anderson
et al. “Association of family history of cervical, ovarian and
uterine cancer with histological categories of
lung
cancer: The Iowa Women’s Health Study.” Cancer Epidemiology,
Biomarkers and Prevention 6,
401-405, June 1997.
•Mayne
et al. “Familial cancer history and lung cancer risk in United
States Nonsmoking men and Women.” Cancer Epidemiology, Biomarkers
and Prevention 8, 1065-1069, december 1999
•Huber
et al. “Chemoprevention of lung cancer”. April 1993, Seminars in
Oncology, Vlo.20, No 2. Lung Cancer Part 1, pp 128-141.
|